Intradermal Rabies Immunization Using NanoJect: A Comparative Study

Clinical trial NCT02538185 · COMPLETED

Trial details

NCT number: NCT02538185
Sponsor: University of Lausanne Hospitals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Intradermal (ID) Vaccination Device

Start date: 2013-08-01
Primary completion: 2014-09-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.